The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis
P. Rossier, S. van Erven and D. T. Wade

Abstract

The effects of magnesium glycerophosphate oral therapy on spasticity was studied in a 35-year-old woman with severe spastic paraplegia resulting from multiple sclerosis (MS). We found a significant improvement in the spasticity after only 1 week from the onset of the treatment on the modified Ashworth scale, an improvement in the range of motion and in the measures of angles at resting position in lower limbs. No side-effects were reported and there was no weakness in the arms during the treatment. http://onlinelibrary.wiley.com/doi/10.1046/j.1468-1331.2000.00142.x/abstract;jsessionid=1B1971B65E9BD989CDD693C186D997BF.f04t02


The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis -...
onlinelibrary.wiley.com
Issue , , Rossier, P., van Erven, S. and Wade, D. T. (2000), The effect of magnesium oral therapy on spasticity in a patient with multiple sclerosis.